Stable Isotope Labeled Biomolecules Market to grow at a CAGR of 5.6% during 2024-2028
The Stable Isotope Labeled Biomolecules Market is expected to grow at a CAGR of 5.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 92.1 million. The stable isotope labeled biomolecules market is experiencing substantial growth, particularly in the pharmaceutical sector, with a focus on drug discovery and development. Iron, an essential element for human health, is frequently deficient, leading to widespread disability. Stable isotope techniques using non-radioactive iron isotopes have become indispensable for evaluating iron kinetics from supplements and fortificants, as well as for investigating the influence of diseases and genetic disorders on iron absorption and excretion. The swift detection of a stable iron isotope in plasma following oral administration enables the rapid assessment of iron absorption rates, quantities, and patterns. Moreover, the erythrocyte iron incorporation method, which assesses both absorption and erythrocyte utilization 14 days post-administration, offers comprehensive insights into iron metabolism.
Get more information on Stable Isotope Labeled Biomolecules Market by requesting a sample report
Technavio analysts predict that the D labeled biomolecules subsegment will lead the Type segment during 2024 and 2028 The stable isotope labeled biomolecules market is experiencing robust growth, with the D labeled biomolecules segment experiencing notable expansion. This segment's expansion is fueled by the expanding utilization of deuterium (D) in various industries, such as pharmaceuticals and semiconductor manufacturing. Deuterated small molecules have emerged as innovative drug leads, necessitating advanced deuteration techniques in drug synthesis. The integration of deuterium into small molecules enhances their metabolic stability and bioavailability, making them more effective therapeutic agents. This trend has resulted in a surge in demand for D labeled biomolecules within the pharmaceutical sector, as researchers and developers aim to harness these advantages to develop more efficient and long-lasting drugs.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish expansion of environmental and ecological research
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The Stable Isotope Labeled Biomolecules market is a significant segment of the life sciences industry, driven by the increasing demand for advanced tools and techniques in metabolomics, structural biology, lipidomics, and scientific research. Stable isotopes, such as Deuterium, Oxygen-18, Nitrogen-15, Carbon-13, and others, are used for isotopic labeling of metabolites, nucleic acids, lipids, and proteins. This process enables metabolism tracking, early detection of diseases like cancer, and development of medical imaging techniques. Custom synthesis of 13C Labeled Biomolecules and 15N Labeled Biomolecules is a crucial aspect of this market. Isotopic labeling facilitates understanding metabolic pathways, neutron count, and isotope distribution, providing valuable insights into biological systems. The market's growth is fueled by the need for carbon neutrality and the increasing use of radiolabeling in research applications. Overall, the Stable Isotope Labeled Biomolecules market plays a vital role in advancing scientific discovery and improving healthcare outcomes.
The Stable Isotope Labeled Biomolecules Market encompasses the earnings derived from the sale of healthcare applications and IT systems, internet-based healthcare tools such as monitoring devices, telehealth technologies, digital health technologies, and IT consulting services to healthcare institutions and businesses. According to Technavio, the global healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, healthcare technology companies, and life sciences tools and services. Factors propelling the expansion of the healthcare technology market include cost reduction pressures affecting both the healthcare industry and IT spending market in developed and emerging economies.
The Stable Isotope Labeled Biomolecules Market is experiencing significant growth, fueled by the expansion of environmental and ecological research. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
